|
|
|
Insider
Information: |
Weiss Michael S |
Relationship: |
Director |
City: |
Berkeley Heights |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
16,329,233 |
|
Indirect Shares
|
14,546,388 |
|
|
Direct
Value |
$216,826,582 |
|
|
Indirect Value
|
$239,124,051 |
|
|
Total
Shares |
30,875,621 |
|
|
Total
Value |
$455,950,633 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
2
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
-2.8%
|
-135.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
10% Owner |
2010-05-10 |
1,320,418 |
2003-11-21 |
0 |
Premium* |
|
Genta Inc De |
GNTAQ |
Director |
2005-08-05 |
537,238 |
2004-07-14 |
0 |
Premium* |
|
XTL Biopharmaceuticals Ltd |
XTLBY |
Director |
2008-08-22 |
25,000 |
|
0 |
Premium* |
|
TG Therapeutics Inc |
TGTX |
CEO |
2024-01-06 |
13,074,929 |
2020-06-22 |
14,434,214 |
Premium* |
|
Fortress Biotech, Inc. |
FBIO |
See Remarks, Director,... |
2024-01-01 |
1,346,985 |
2013-12-19 |
0 |
Premium* |
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2017-06-15 |
0 |
2024-05-14 |
112,174 |
Premium* |
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2018-08-07 |
24,663 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
126 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-06-20 |
4 |
OE |
$1.30 |
$52,000 |
D/D |
40,000 |
55,000 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-07-18 |
4 |
OE |
$1.30 |
$13,000 |
D/D |
10,000 |
25,000 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-07-18 |
4 |
AS |
$11.41 |
$116,098 |
D/D |
(10,000) |
15,000 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-07 |
4 |
AS |
$14.49 |
$779,556 |
D/D |
(53,435) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-07 |
4 |
OE |
$1.30 |
$69,466 |
D/D |
53,435 |
68,435 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-08 |
4 |
AS |
$14.49 |
$395,476 |
D/D |
(27,102) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-08 |
4 |
OE |
$1.30 |
$35,233 |
D/D |
27,102 |
42,102 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-11 |
4 |
OE |
$1.30 |
$29,764 |
D/D |
22,895 |
37,895 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-11 |
4 |
AS |
$14.40 |
$267,640 |
D/D |
(18,500) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-11 |
4 |
AS |
$14.53 |
$64,101 |
D/D |
(4,395) |
33,500 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-12 |
4 |
AS |
$14.40 |
$216,306 |
D/D |
(15,000) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-12 |
4 |
OE |
$1.30 |
$19,500 |
D/D |
15,000 |
30,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-13 |
4 |
OE |
$1.30 |
$27,738 |
D/D |
21,337 |
36,337 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-13 |
4 |
AS |
$14.30 |
$306,176 |
D/D |
(21,337) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-14 |
4 |
AS |
$14.14 |
$325,088 |
D/D |
(22,887) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-14 |
4 |
OE |
$1.30 |
$29,753 |
D/D |
22,887 |
37,887 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-15 |
4 |
AS |
$14.09 |
$360,530 |
D/D |
(25,433) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-15 |
4 |
OE |
$1.30 |
$33,063 |
D/D |
25,433 |
40,433 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-18 |
4 |
AS |
$13.70 |
$163,341 |
D/D |
(11,911) |
15,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
|
2006-12-18 |
4 |
OE |
$1.30 |
$15,484 |
D/D |
11,911 |
26,911 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2008-08-22 |
4 |
B |
$0.40 |
$40,000 |
D/D |
100,000 |
115,000 |
2.81 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2008-08-26 |
4 |
B |
$0.41 |
$20,500 |
D/D |
50,000 |
165,000 |
2.81 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2008-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800,000 |
1,965,000 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
|
2009-01-28 |
5 |
S |
$3.06 |
$156,978 |
D/D |
(51,300) |
1,913,700 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
|
2009-02-03 |
5 |
S |
$2.70 |
$69,428 |
D/D |
(25,714) |
1,887,986 |
0 |
- |
|
126 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|